Assessing the feasibility of NaF or FDG as PET probes to evaluate atherosclerosis in rheumatoid arthritis patients

Siavash Mehdizadeh Seraj, William Raynor, Chaitanya Rojulpote, Mahdi Zirakchian Zadeh, Leila Arani, Thomas Werner, Poul Flemming Høilund-Carlsen, Joshua Baker, Abass Alavi, Stephen S. Hunt

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

OriginalsprogEngelsk
Artikelnummer1439
TidsskriftJournal of Nuclear Medicine
Vol/bind60
Udgave nummerSupplement 1
ISSN0161-5505
StatusUdgivet - 1. maj 2019
BegivenhedEANM Annual Congress 2019 - Barcelona, Spanien
Varighed: 12. okt. 201916. okt. 2019

Konference

KonferenceEANM Annual Congress 2019
LandSpanien
ByBarcelona
Periode12/10/201916/10/2019

Citer dette

Seraj, S. M., Raynor, W., Rojulpote, C., Zadeh, M. Z., Arani, L., Werner, T., ... Hunt, S. S. (2019). Assessing the feasibility of NaF or FDG as PET probes to evaluate atherosclerosis in rheumatoid arthritis patients. Journal of Nuclear Medicine, 60(Supplement 1), [1439].
Seraj, Siavash Mehdizadeh ; Raynor, William ; Rojulpote, Chaitanya ; Zadeh, Mahdi Zirakchian ; Arani, Leila ; Werner, Thomas ; Høilund-Carlsen, Poul Flemming ; Baker, Joshua ; Alavi, Abass ; Hunt, Stephen S. / Assessing the feasibility of NaF or FDG as PET probes to evaluate atherosclerosis in rheumatoid arthritis patients. I: Journal of Nuclear Medicine. 2019 ; Bind 60, Nr. Supplement 1.
@article{c3d18a30cfa7418c96f8f7f87c57776e,
title = "Assessing the feasibility of NaF or FDG as PET probes to evaluate atherosclerosis in rheumatoid arthritis patients",
author = "Seraj, {Siavash Mehdizadeh} and William Raynor and Chaitanya Rojulpote and Zadeh, {Mahdi Zirakchian} and Leila Arani and Thomas Werner and H{\o}ilund-Carlsen, {Poul Flemming} and Joshua Baker and Abass Alavi and Hunt, {Stephen S.}",
year = "2019",
month = "5",
day = "1",
language = "English",
volume = "60",
journal = "Journal of Nuclear Medicine",
issn = "0161-5505",
publisher = "Society of Nuclear Medicine",
number = "Supplement 1",

}

Seraj, SM, Raynor, W, Rojulpote, C, Zadeh, MZ, Arani, L, Werner, T, Høilund-Carlsen, PF, Baker, J, Alavi, A & Hunt, SS 2019, 'Assessing the feasibility of NaF or FDG as PET probes to evaluate atherosclerosis in rheumatoid arthritis patients', Journal of Nuclear Medicine, bind 60, nr. Supplement 1, 1439.

Assessing the feasibility of NaF or FDG as PET probes to evaluate atherosclerosis in rheumatoid arthritis patients. / Seraj, Siavash Mehdizadeh; Raynor, William; Rojulpote, Chaitanya; Zadeh, Mahdi Zirakchian; Arani, Leila; Werner, Thomas; Høilund-Carlsen, Poul Flemming; Baker, Joshua; Alavi, Abass; Hunt, Stephen S.

I: Journal of Nuclear Medicine, Bind 60, Nr. Supplement 1, 1439, 01.05.2019.

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

TY - ABST

T1 - Assessing the feasibility of NaF or FDG as PET probes to evaluate atherosclerosis in rheumatoid arthritis patients

AU - Seraj, Siavash Mehdizadeh

AU - Raynor, William

AU - Rojulpote, Chaitanya

AU - Zadeh, Mahdi Zirakchian

AU - Arani, Leila

AU - Werner, Thomas

AU - Høilund-Carlsen, Poul Flemming

AU - Baker, Joshua

AU - Alavi, Abass

AU - Hunt, Stephen S.

PY - 2019/5/1

Y1 - 2019/5/1

M3 - Conference abstract in journal

VL - 60

JO - Journal of Nuclear Medicine

JF - Journal of Nuclear Medicine

SN - 0161-5505

IS - Supplement 1

M1 - 1439

ER -

Seraj SM, Raynor W, Rojulpote C, Zadeh MZ, Arani L, Werner T et al. Assessing the feasibility of NaF or FDG as PET probes to evaluate atherosclerosis in rheumatoid arthritis patients. Journal of Nuclear Medicine. 2019 maj 1;60(Supplement 1). 1439.